{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T02:10:39Z","timestamp":1689041439082},"reference-count":32,"publisher":"Japanese Pharmacological Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Folia Pharmacol. Jpn."],"published-print":{"date-parts":[[2014]]},"DOI":"10.1254\/fpj.143.144","type":"journal-article","created":{"date-parts":[[2014,3,10]],"date-time":"2014-03-10T01:46:10Z","timestamp":1394415970000},"page":"144-151","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacological properties and clinical efficacy of tetrabenazine \uff08Choreazine^|^#174;Tablets 12.5 mg\uff09, a therapeutic agent for non-rhythmic involuntary movement"],"prefix":"10.1254","volume":"143","author":[{"given":"Kouichi","family":"Machida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masuo","family":"Miki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","reference":[{"key":"1"},{"key":"2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Walker FO. Lancet. 2007;369:218-228.","DOI":"10.1016\/S0140-6736(07)60111-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Scherman D. J Neurochem. 1986;47:331-339.","DOI":"10.1111\/j.1471-4159.1986.tb04506.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Scherman D, et al. Proc Natl Acad Sci U S A. 1983;80:584-588.","DOI":"10.1073\/pnas.80.2.584"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Scherman D, et al. Mol Pharmacol. 1987;33:72-77.","DOI":"10.3406\/hedu.1987.1455"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Erickson JD, et al. Proc Natl Acad Sci U S A. 1996;93:5166-5171.","DOI":"10.1073\/pnas.93.10.5166"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Login IS, et al. Ann Neurol. 1982;12:257-262.","DOI":"10.1002\/ana.410120308"},{"key":"9","unstructured":"9) André VM, et al. Front Syst Neurosci. 2011;5:1-11."},{"key":"10","unstructured":"10)Xenazine® Homepage(http\/\/www.xenazineusa.com\/HCP\/MOA)"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) The Huntington’s Disease Collaborative Research Group. Cell. 1993;72:971-983.","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Gatchel JR, et al. Nat Rev Genet. 2005;6:743-755.","DOI":"10.1038\/nrg1691"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Di Prospero NA, et al. Nat Rev Genet. 2005;6:756-765.","DOI":"10.1038\/nrg1690"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Van Raamsdonk JM, et al. Hum Mol Genet. 2005;14:1379-1392.","DOI":"10.1093\/hmg\/ddi147"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Menalled L, et al. Neurobiol Dis. 2009;35:319-336.","DOI":"10.3166\/rfg.198-199.319-342"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) André VM, et al. J Neurosci. 2011;31:1170-1182.","DOI":"10.1523\/JNEUROSCI.3539-10.2011"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Spielewoy C, et al. Behav Pharmacol. 2000;11:279-290.","DOI":"10.1097\/00008877-200006000-00011"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Wang H, et al. Mol Neurodegener. 2010;5:18-29.","DOI":"10.1021\/om1006903"},{"key":"19"},{"key":"20"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Pettibone DJ, et al. Eur J Pharmacol. 1984;102:425-430.","DOI":"10.1016\/0014-2999(84)90562-4"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Hong M, et al. Neuropharmacol. 1987;26:1061-1069.","DOI":"10.1016\/0028-3908(87)90249-8"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) DaSilva JN, et al. Life Sci 1992;51:593-600.","DOI":"10.1016\/0024-3205(92)90228-H"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) DaSilva JN, et al. Synapse. 1993;14:128-131.","DOI":"10.1002\/syn.890140205"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Koeppe RA, et al. J Cereb Blood Flow Metab. 1997;17:919-931.","DOI":"10.1097\/00004647-199709000-00001"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Thibaut F, et al. Brain Res. 1995;692:233-243.","DOI":"10.1016\/0006-8993(95)00674-F"},{"key":"27"},{"key":"28"},{"key":"29"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Huntington Study Group. Neurology. 2006;66:366-372.","DOI":"10.1212\/01.wnl.0000198586.85250.13"},{"key":"31"},{"key":"32","unstructured":"32) Frank S. Neurology. 2009;9:62."}],"container-title":["Folia Pharmacologica Japonica"],"original-title":["\u975e\u5f8b\u52d5\u6027\u4e0d\u968f\u610f\u904b\u52d5\u6cbb\u7642\u85ac\u30c6\u30c8\u30e9\u30d9\u30ca\u30b8\u30f3\uff08\u30b3\u30ec\u30a2\u30b8\u30f3<sup>®<\/sup>\u932012.5 mg\uff09\u306e\u85ac\u7406\u5b66\u7684\u7279\u6027\u3068\u81e8\u5e8a\u52b9\u679c"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fpj\/143\/3\/143_144\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T01:50:16Z","timestamp":1689040216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fpj\/143\/3\/143_144\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1254\/fpj.143.144","relation":{},"ISSN":["0015-5691","1347-8397"],"issn-type":[{"value":"0015-5691","type":"print"},{"value":"1347-8397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}